Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, and BaseSolve, a leading provider of advanced bioinformatic analysis and reporting, today announced a U.S.-focused co-marketing agreement to offer customers a powerful, integrated solution for Next-Generation Sequencing (NGS) workflows. This co-marketing agreement applies exclusively to customers within the United States region.
The collaboration will provide laboratories in the U.S. with a streamlined NGS workflow solution beginning with quality control of the sample, followed by library preparation and Target Enrichment and ending with data reporting. The integrated offering combines Agilent’s portfolio of trusted genomics instrumentation and reagents with BaseSolve’s innovative software solutions. This workflow has been optimized for both Element and Illumina sequencers in the U.S.
Integrated Technologies for Precision Genomics
The agreement focuses on delivering a tested and supported integrated solution.
Agilent’s Genomics Systems:
Agilent provides a comprehensive suite of tools for sample and library preparation, and quality control, including SureSelect, Avida, Magnis, NGS Bravo/NGS Bravo Workstation, TapeStation, Fragment Analyzer, and Femto Pulse Automated Electrophoresis Systems.
BaseSolve’s Bioinformatic Platform:
BaseSolve offers sophisticated bioinformatic analysis and reporting through its flagship AUGMETTM platform. AUGMETTM is an end-to-end analysis and reporting suite designed to support NGS workflows, focusing on accuracy, scalability, and compliance.
This collaboration is particularly aimed at enhancing the Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) workflows, providing a pathway for research laboratories to adopt the combined solution efficiently.
“This co-marketing agreement with BaseSolve is a testament to our commitment to accelerating genomics and scientific discovery,” said Majken Nielsen, Vice President Clinical Businesses, Clinical Diagnostics Division at Agilent Technologies. “By pairing our robust, high-quality sample prep and automation systems with BaseSolve’s expert bioinformatic analysis, we are removing complexity and enabling our research customers to achieve rapid, reliable, and standardized results in their labs.”
“The fully executed co-marketing agreement with Agilent marks an exciting milestone for BaseSolve and our AUGMETTM platform,” said Dr. Anupam J Das. “Customers can now easily access an integrated solution that leverages the quality of Agilent’s instrumentation with our advanced analysis and reporting capabilities. We look forward to supporting translational research labs globally, particularly within the United States where this solution is immediately accessible through Agilent’s quoting structure.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering innovative solutions that help customers gain the insights they seek. Agilent’s instruments, software, services, solutions, and consumables are used by laboratories worldwide to address the full scope of their scientific needs.
About BaseSolveTM
BaseSolve Informatics Private Limited is a global provider of cutting-edge bioinformatic analysis and reporting solutions for research laboratories. Its flagship platform, AUGMETTM, delivers end-to-end support for complex genomics workflows. BaseSolve is committed to scalable, compliant, and accurate data analysis.
Contact
Dr. Anupam J Das, PhD
Cofounder & COO BaseSolve Informatics
https://www.basesolve.com | https://augmet.ai
Melanie Herscovitch, PhD
Market Specialist Manager, AFO
Healthcare Diagnostics
